254 related articles for article (PubMed ID: 18041309)
21. Serum C-reactive protein level in postsplenectomized thalassemic patients.
Archararit N; Chuncharunee S; Pornvoranunt A; Atamasirikul K; Rachakom B; Atichartakarn V
J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S63-9. PubMed ID: 10865409
[TBL] [Abstract][Full Text] [Related]
22. Morphological assessment of platelet activation in thalassemia.
Bunyaratvej A; Komanasin N; Sriurairatana S; Fucharoen S
Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():60-4. PubMed ID: 1298995
[TBL] [Abstract][Full Text] [Related]
23. Flow cytometric analysis of fetal hemoglobin in erythroid precursors of beta-thalassemia.
Amoyal I; Fibach E
Clin Lab Haematol; 2004 Jun; 26(3):187-93. PubMed ID: 15163316
[TBL] [Abstract][Full Text] [Related]
24. In vivo and in vitro studies of fetal hemoglobin induction by hydroxyurea in beta-thalassemia/hemoglobin E patients.
Watanapokasin Y; Chuncharunee S; Sanmund D; Kongnium W; Winichagoon P; Rodgers GP; Fucharoen S
Exp Hematol; 2005 Dec; 33(12):1486-92. PubMed ID: 16338491
[TBL] [Abstract][Full Text] [Related]
25. Increased erythropoiesis of beta-thalassaemia/Hb E proerythroblasts is mediated by high basal levels of ERK1/2 activation.
Wannatung T; Lithanatudom P; Leecharoenkiat A; Svasti S; Fucharoen S; Smith DR
Br J Haematol; 2009 Sep; 146(5):557-68. PubMed ID: 19594742
[TBL] [Abstract][Full Text] [Related]
26. Hemoglobin-bound platelets correlate with the increased platelet activity in hemoglobin E/β-thalassemia.
Chamchoi A; Srihirun S; Paiboonsukwong K; Sriwantana T; Kongkaew P; Fucharoen S; Pattanapanyasat K; Sibmooh N
Int J Lab Hematol; 2020 Oct; 42(5):518-525. PubMed ID: 32539231
[TBL] [Abstract][Full Text] [Related]
27. Premature senescence of T lymphocytes from patients with beta-thalassemia major.
Gharagozloo M; Bagherpour B; Tahanian M; Oreizy F; Amirghofran Z; Sadeghi HM; Hourfar H; Moayedi B
Immunol Lett; 2009 Jan; 122(1):84-8. PubMed ID: 19118576
[TBL] [Abstract][Full Text] [Related]
28. Phosphoproteomic analysis of apoptotic hematopoietic stem cells from hemoglobin E/β-thalassemia.
Ponnikorn S; Panichakul T; Sresanga K; Wongborisuth C; Roytrakul S; Hongeng S; Tungpradabkul S
J Transl Med; 2011 Jun; 9():96. PubMed ID: 21702968
[TBL] [Abstract][Full Text] [Related]
29. Enhanced oxidative cross-linking of hemoglobin E with spectrin and loss of erythrocyte membrane asymmetry in hemoglobin Ebeta-thalassemia.
Datta P; Basu S; Chakravarty SB; Chakravarty A; Banerjee D; Chandra S; Chakrabarti A
Blood Cells Mol Dis; 2006; 37(2):77-81. PubMed ID: 16877015
[TBL] [Abstract][Full Text] [Related]
30. Double-faced cell-mediated immunity in beta-thalassemia major: stimulated phenotype versus suppressed activity.
Gharagozloo M; Karimi M; Amirghofran Z
Ann Hematol; 2009 Jan; 88(1):21-7. PubMed ID: 18690440
[TBL] [Abstract][Full Text] [Related]
31. Association of the Degree of Erythroid Expansion and Maturation Arrest with the Clinical Severity of β0-Thalassemia/Hemoglobin E Patients.
Suriyun T; Kaewsakulthong W; Khamphikham P; Chumchuen S; Hongeng S; Fucharoen S; Sripichai O
Acta Haematol; 2021; 144(6):660-671. PubMed ID: 34535581
[TBL] [Abstract][Full Text] [Related]
32. Microparticles from splenectomized β-thalassemia/HbE patients play roles on procoagulant activities with thrombotic potential.
Klaihmon P; Phongpao K; Kheansaard W; Noulsri E; Khuhapinant A; Fucharoen S; Morales NP; Svasti S; Pattanapanyasat K; Chaichompoo P
Ann Hematol; 2017 Feb; 96(2):189-198. PubMed ID: 27900452
[TBL] [Abstract][Full Text] [Related]
33. Exogenous iron increases hemoglobin in beta-thalassemic mice.
Ginzburg YZ; Rybicki AC; Suzuka SM; Hall CB; Breuer W; Cabantchik ZI; Bouhassira EE; Fabry ME; Nagel RL
Exp Hematol; 2009 Feb; 37(2):172-83. PubMed ID: 19059700
[TBL] [Abstract][Full Text] [Related]
34. Protein C and protein S deficiency in thalassemic patients.
Shirahata A; Funahara Y; Opartkiattikul N; Fucharoen S; Laosombat V; Yamada K
Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():65-73. PubMed ID: 1298996
[TBL] [Abstract][Full Text] [Related]
35. Impaired Terminal Erythroid Maturation in β
Suriyun T; Winichagoon P; Fucharoen S; Sripichai O
J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407362
[TBL] [Abstract][Full Text] [Related]
36. UNC0638 induces high levels of fetal hemoglobin expression in β-thalassemia/HbE erythroid progenitor cells.
Nualkaew T; Khamphikham P; Pongpaksupasin P; Kaewsakulthong W; Songdej D; Paiboonsukwong K; Sripichai O; Engel JD; Hongeng S; Fucharoen S; Jearawiriyapaisarn N
Ann Hematol; 2020 Sep; 99(9):2027-2036. PubMed ID: 32567028
[TBL] [Abstract][Full Text] [Related]
37. Expression of red cell surface antigens during erythropoiesis.
Daniels G; Green C
Vox Sang; 2000; 78 Suppl 2():149-53. PubMed ID: 10938945
[TBL] [Abstract][Full Text] [Related]
38. Ineffective erythropoiesis in mutant mice with deficient pyruvate kinase activity.
Aizawa S; Harada T; Kanbe E; Tsuboi I; Aisaki K; Fujii H; Kanno H
Exp Hematol; 2005 Nov; 33(11):1292-8. PubMed ID: 16263413
[TBL] [Abstract][Full Text] [Related]
39. Vanadate elevates fetal hemoglobin in human erythroid precursors by inhibiting cell maturation.
Amoyal I; Prus E; Fibach E
Exp Biol Med (Maywood); 2007 May; 232(5):654-61. PubMed ID: 17463162
[TBL] [Abstract][Full Text] [Related]
40. Homeostatic erythropoiesis by the transcription factor IRF2 through attenuation of type I interferon signaling.
Mizutani T; Tsuji K; Ebihara Y; Taki S; Ohba Y; Taniguchi T; Honda K
Exp Hematol; 2008 Mar; 36(3):255-64. PubMed ID: 18207304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
